Latest

1 story

Hide weekly roundups

Tuesday, September 29

Lilly posts Lyumjev safety results in India; registers new Alzheimer's Phase 1 study

Weekly roundup, 5 itemsbaricitinib Cipla

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.